 |
Ac-Leu-Thr-Phe-c[(R)-2-amino-2-methyldec-9-enoic acid-Glu-Tyr-Trp-Ala-Gln-Leu-(S)-2-amino-2-methylhept-6-enoic acid]1-Ala-Ala-Ala-Ala-Ala-D-Ala-NH2 |
|---|---|
| Trade Name | |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2017-04-19 00:00:00 |
| Sponsor | Aileron Therapeutics, Inc.;81 Albany Street;Cambridge, Massachusetts, 02139 |
